Qing Lu Selected Research

Hormones (Hormone)

1/2020	The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity.
1/2020	The association between high levels of luteinizing hormone and proliferative retinopathy of prematurity in female preterm infants.
1/2018	Membrane-Initiated Estrogen Receptor Signaling Mediates Metabolic Homeostasis via Central Activation of Protein Phosphatase 2A.
11/2014	Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.
11/2003	The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Lu Research Topics

Disease

49	Neoplasms (Cancer) 01/2024 - 11/2003
17	Acute Lung Injury 05/2024 - 06/2010
17	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2003
17	Inflammation (Inflammations) 12/2023 - 11/2014
17	Hypertension (High Blood Pressure) 10/2023 - 05/2002
15	Hypoxia (Hypoxemia) 12/2023 - 02/2002
13	Ischemia 02/2024 - 06/2007
11	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 01/2019
10	Atherosclerosis 11/2021 - 06/2003
9	Brain Injuries (Brain Injury) 05/2023 - 10/2011
8	Lung Injury 05/2024 - 03/2013
8	Sepsis (Septicemia) 05/2024 - 07/2012
8	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2003
8	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 01/2012
7	Edema (Dropsy) 05/2024 - 01/2008
7	Fibrosis (Cirrhosis) 01/2023 - 08/2006
7	Cognitive Dysfunction 01/2023 - 10/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2010
7	Lymphedema (Milroy Disease) 01/2018 - 04/2009
7	Brain Ischemia (Cerebral Ischemia) 10/2016 - 11/2005
6	Infections 01/2024 - 05/2003
6	Obesity 11/2023 - 01/2018
6	Pulmonary Hypertension 01/2023 - 01/2016
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2022 - 03/2003
6	Infarction (Infarctions) 01/2021 - 11/2005
6	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2004
6	Leiomyoma (Uterine Fibroids) 07/2019 - 01/2016
5	Pneumonia (Pneumonitis) 05/2024 - 08/2006
5	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 03/2007
5	Vascular Diseases (Vascular Disease) 12/2023 - 07/2008
5	Neuroinflammatory Diseases 03/2023 - 01/2017
5	Vascular System Injuries 01/2017 - 03/2007
5	Heart Failure 01/2015 - 01/2002
4	Reperfusion Injury 02/2024 - 04/2011
4	Osteoporosis 09/2023 - 01/2022
4	Yang Deficiency (Xu, Yang) 07/2023 - 01/2022
4	Necrosis 01/2023 - 03/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2019
4	Nervous System Diseases (Neurological Disorders) 03/2021 - 01/2007
4	Lung Diseases (Lung Disease) 01/2021 - 03/2013
4	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2003
4	Emphysema 01/2018 - 07/2008
4	Stroke (Strokes) 11/2017 - 11/2005
4	Ischemic Stroke 05/2016 - 01/2015
4	Choroidal Neovascularization 01/2016 - 05/2012
3	Liver Failure 12/2023 - 01/2017
3	Acute-On-Chronic Liver Failure 12/2023 - 03/2017
3	Phenylketonurias (Phenylketonuria) 01/2023 - 11/2019
3	Hypothermia 01/2023 - 02/2002
3	Carcinogenesis 01/2023 - 09/2004

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2007
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2012
12	SmokeIBA 01/2023 - 12/2011
11	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2008
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
10	LipopolysaccharidesIBA 01/2023 - 01/2012
10	Estrogens (Estrogen)FDA Link 01/2023 - 03/2007
8	Antidepressive Agents (Antidepressants)IBA 04/2024 - 01/2020
8	Oxygen (Dioxygen)IBA 02/2024 - 04/2011
8	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 06/2014
8	bisphenol AIBA 01/2022 - 01/2016
7	CytokinesIBA 11/2023 - 03/2003
7	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2023 - 01/2018
7	Estrogen ReceptorsIBA 10/2022 - 12/2009
6	Contrast MediaIBA 01/2022 - 04/2009
6	Adenosine (Adenocard)FDA LinkGeneric 04/2020 - 06/2010
5	LipidsIBA 10/2023 - 02/2003
5	Messenger RNA (mRNA)IBA 06/2023 - 06/2005
5	RNA (Ribonucleic Acid)IBA 06/2023 - 03/2007
5	InflammasomesIBA 11/2022 - 01/2017
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2009
5	Hormones (Hormone)IBA 01/2020 - 11/2003
5	LigandsIBA 01/2019 - 11/2015
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 06/2003
4	Long Noncoding RNAIBA 01/2024 - 02/2012
4	Hemoglobins (Hemoglobin)IBA 01/2024 - 02/2002
4	Amino Acids FDA Link 09/2023 - 12/2022
4	gushudanIBA 07/2023 - 01/2022
4	MicroRNAs (MicroRNA)IBA 06/2023 - 01/2020
4	IronIBA 01/2023 - 12/2015
4	EnzymesIBA 01/2022 - 05/2002
4	AntioxidantsIBA 03/2021 - 12/2009
4	Cyclic NucleotidesIBA 01/2021 - 10/2014
4	thiamine triphosphorate (TTP)IBA 10/2019 - 02/2015
4	Estrogen Receptor alphaIBA 06/2018 - 03/2007
4	salicylhydroxamic acid (SHAM)IBA 10/2016 - 01/2002
3	AlbuminsIBA 01/2024 - 06/2020
3	Indicators and Reagents (Reagents)IBA 10/2023 - 08/2015
3	CholesterolIBA 07/2023 - 01/2011
3	NucleotidesIBA 07/2023 - 01/2016
3	NF-kappa B (NF-kB)IBA 06/2023 - 03/2022
3	tanshinone II A sodium sulfonateIBA 05/2023 - 07/2012
3	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2023 - 11/2019
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2022 - 06/2005

Therapy/Procedure

28	Therapeutics 12/2023 - 06/2003
8	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
6	Ligation 06/2023 - 07/2012
5	Aftercare (After-Treatment) 08/2021 - 01/2014
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2023 - 10/2020
4	Lasers (Laser) 01/2018 - 05/2012